Orgenesis

Orgenesis Inc. is on a mission to democratize access to cell and gene therapies by decentralizing their manufacturing. The company has developed the integrated POCare Platform, which combines a pipeline of therapeutic programs, validated automated processing technologies, and a global network of hospital partners to enable local production at the point of care. This strategy seeks to drastically reduce costs, simplify logistics, and accelerate the delivery of personalized therapies to patients worldwide, positioning Orgenesis as a unique enabler in the CGT ecosystem.

The POCare Platform is a decentralized, three-pillar ecosystem comprising Therapies (a pipeline of CGT assets), Technologies (validated automated processing systems like the OMPUL™ mobile unit), and a global Network of hospital partners to enable local, standardized, point-of-care manufacturing.